Hyperbaric Oxygen Therapy in COVID-19 Treatment : Efficacy and Safety

• Autorzy: Ubysz Dorota , Giermaziak Wojciech , Ostrowska Aurelia

Identyfikatory

DOI

10.2478/phr-2021-0009

Warianty tytułu

PL

Hiperbaria tlenowa w leczeniu COVID-19 : skuteczność i bezpieczeństwo

• Języki publikacji: EN PL

Abstrakty

EN

Introduction: New effective treatments are sought to eliminate COVID-19-related hypoxia. Hyperbaric oxygen therapy is an effective method in the treatment of many diseases accompanied by hypoxia. Aim: The aim of this study was to analyse the literature on the use of hyperbaric oxygen in the treatment of COVID-19 and to evaluate the effectiveness and safety of this method. Materials and methods: Medical databases (Medline and PBL) and websites were reviewed using the terms hyperbaric oxygen and COVID-19. 25 works were qualified for the analysis. Conclusions: The analysed literature shows that hyperbaric oxygen therapy is an effective and safe method of treating patients with COVID-19. Due to the limited amount of scientific evidence assessing the use of HBOT in COVID-19, there is a need for further research to confirm the effectiveness and safety of this method.

PL

Wstęp: Do eliminowania hipoksji związanej z COVID-19 poszukiwane są nowe sposoby skutecznego leczenia. Tlenoteriapia hiperbaryczna jest skuteczną metodą w leczeniu wielu chorób z towarzyszącą hipoksją. Cel: Celem niniejszej pracy było przeanalizowanie literatury dotyczącej zastosowania hiperbarii tlenowej w leczeniu COVID-19 oraz ocena skuteczności i bezpieczeństwa tej metody. Materiały i metody: Dokonano przeglądu medycznych baz danych (Medline i PBL) oraz stron internetowych za pomocą haseł: hiperbaria tlenowa i COVID-19. Do analizy zakwalifikowano 25 prac. Wnioski: Z przeanalizowanej literatury wynika, że tlenoterapia hiperbaryczna jest skuteczną i bezpieczną metodą leczenia pacjentów z COVID-19. Ze względu na ograniczoną liczbę dowodów naukowych oceniających stosowanie HBOT w COVID-19, istnieje potrzeba przeprowadzania dalszych badań potwierdzających skuteczność i bezpieczeństwo tej metody.

Słowa kluczowe

EN

hyperbaric oxygen; COVID-19; hypoxia

PL

hiperbaria tlenowa; COVID-19; niedotlenienie

• Wydawca: Polskie Towarzystwo Medycyny i Techniki Hiperbarycznej
• Czasopismo: Polish Hyperbaric Research
• Rocznik: 2021
• Tom: nr 2(75)
• Strony: 25--40
• Opis fizyczny: Bibliogr. 25 poz., rys.

Twórcy

autor

Ubysz Dorota

• Main Medical Library in Warsaw, Poland

autor

Giermaziak Wojciech

• Main Medical Library in Warsaw, Poland

autor

Ostrowska Aurelia

• Military Medical Service Department in Warsaw, Poland

Bibliografia

• 1. Płusa Tadeusz, Baranowski Paweł. Tlenoterapia w niewydolności oddechowej. Intern. Rev. Med. Pract. 2021: 27 (2): 70-76;
• 2. Oliaei Shahram, SeyedAlinaghi SeyedAhmad, Mehrtak Mohammad, Karimi Amirali, Noori Tayebeh, Mirzapour Pegah, Shojaei Alireza, MohsseniPour Mehrzad, Mirghaderi Seyed Peyman, Alilou Sanam, Shobeiri Parnian, Cheshmekabodi Hadiseh Azadi, Mehraeen Esmaeil, Dadras Omid: The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. . Eur J Med. Res. 2021; 26(96): 1-12;
• 3. Criado Paulo Ricardo, Miot Hélio Amante, Pincelli Thais Prota Hussein, Fabro Alexandre Todorovic: From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatologic Therapy. 2021; 34: e14565;
• 4. Ortega Miguel A., Martinez Oscar Fraile, García-Montero Cielo, Callejón-Peláez Enrique, Sáez Miguel A., Álvarez-Mon Miguel A., García-Honduvilla Natalio, Monserrat Jorg, Álvarez-Mon Melchor, Bujan Julia, Canals María Luisa: A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina 2021, 57, 864;
• 5. Boet S, Etherington C, Djaiani G, Tricco AC, Sikora L, Katznelson R: Efficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review. Diving & Hyperbaric Medicine. 2021; 51(3): 271-281;
• 6. De Maio Antonio, Hightower Lawrence E.: COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress and Chaperones.2020; 25: 717–720;
• 7. Kjellberg A, De Maio A, Lindholm P: Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19? Medical Hypotheses. 2020; 144: 110224;
• 8. Harch P.: Hyperbaric oxygen treatment of novel coronavirus (coVID-19) respiratory failure. Medical Gas Research | Published by Wolters Kluwer – Medknow. 2020: 61061;
• 9. James PB: Intermittent high dosage oxygen treats COVID-19 infection: the Chinese studies. Medical Gas Research. 2020; 10(2): 63;
• 10. Ylikoski J., Markkanen M.: COViD-19 deaths can be reduced – simply and safely! Medical Gas Research. 2020; 10(3): 139;
• 11. Geier Mark R., Geier David A.: Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality. Medical Hypotheses 140 (2020) 109760: 1-5;
• 12. Feldmeier JJ, Kirby JP, Buckey JC, Denham DW, Evangelista JS, Gelly HB, Harlan NP, Mirza ZK, Ray KL, Robins M, Savaser DJ, Wainwright S, Bird N, Huang ET, Moon RE, Thom SR, Weaver LK: Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen. Undersea & Hyperbaric Medicine. 2021; 48(1): 1-12;
• 13. Kipshidze N, Dangas G, White CJ, Kipshidze N, Siddiqui F, Lattimer CR, Carter CA, Fareed J: Viral Coagulopathy in Patients with COVID-19: Treatment and Care. Clinical & Applied Thrombosis/Hemostasis. 2020; 26: 1076029620936776;
• 14. El Hawa AAA, Charipova K, Bekeny JC, Johnson-Arbor KK: The evolving use of hyperbaric oxygen therapy during the COVID-19 pandemic. Journal of Wound Care. 2021; 30(Sup2): S8-S11;
• 15. Perdrizet G, Hightower LE: On barring the vascular gateway against severe COVID-19 disease. Cell Stress & Chaperones. 2020; 25(5): 721-723;
• 16. Moon RE, Weaver LK: Hyperbaric oxygen as a treatment for COVID-19 infection?. Undersea & Hyperbaric Medicine. 2020; 47(2): 177-179;
• 17. Paganini M, Bosco G, Perozzo FAG, Kohlscheen E, Sonda R, Bassetto F, Garetto G, Camporesi EM, Thom SR: The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review. Advances in Experimental Medicine & Biology. 2021; 1289: 27-35;
• 18. Simon Mitchell J.: Diving and hyperbaric medicine in the SARS-CoV-2 pandemic. Diving and Hyperbaric Medicine; 2020; 50(2): 90-91;
• 19. Anonymous: UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients. Undersea & Hyperbaric Medicine. 2020; 47(2): 297-298;
• 20. Rationale, Study design considerations and protocol recommendations for treating COVID-19 patients with hyperbaric oxygen. https://www.uhms.org/images/MiscDocs/Rational_and_study_design_for_treating_COVID_patients_with_HBO2.pdf [acess 18.02.2022];
• 21. Gorenstein Scott A., Castellano Michael L., Slone Eric S., Gillette Brian, Liu Helen, Alsamarraie Cindy, Jacobson Alan M., Wall Stephen P., Adhikari Samrachana, Swartz Jordan L., McMullen Jenica J.S., Osorio Marcela, Koziatek Christian A., Lee David C.. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls. Clinical Trial Undersea Hyperb Med. Third-Quarter 2020; 47(3): 405-413;
• 22. Guo D, Pan S, Wang M, Guo Y: Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports. Undersea & Hyperbaric Medicine. 2020; 47(2): 181-187;
• 23. Thibodeaux K, Speyrer M, Raza A, Yaakov R, Serena TE: Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series. Journal of Wound Care. 2020; 29(Sup5a): S4-S8;
• 24. Robbins T, Gonevski M, Clark C, Baitule S, Sharma K, Magar A, Patel K, Sankar S, Kyrou I, Ali A, Randeva HS: Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clinical Medicine. 2021; 21(6): e629-e632;
• 25. Cannellotto M, Duarte M, Keller G, Larrea R, Cunto E, Chediack V, Mansur M, Brito DM, Garcia E, Di Salvo HE, Verdini F, Dominguez C, Jorda-Vargas L, Roberti J, Di Girolamo G, Estrada E: Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial. Emergency Medicine Journal. 2022; 39(2): 88-93;